These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36876696)

  • 61. (18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status.
    Lovinfosse P; Koopmansch B; Lambert F; Jodogne S; Kustermans G; Hatt M; Visvikis D; Seidel L; Polus M; Albert A; Delvenne P; Hustinx R
    Br J Radiol; 2016 Jul; 89(1063):20160212. PubMed ID: 27146067
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma.
    Choi ES; Ha SG; Kim HS; Ha JH; Paeng JC; Han I
    Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1836-42. PubMed ID: 23880967
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Value of integrated PET-IVIM MR in assessing metastases in hypermetabolic pelvic lymph nodes in cervical cancer: a multi-parameter study.
    Xu C; Du S; Zhang S; Wang B; Dong C; Sun H
    Eur Radiol; 2020 May; 30(5):2483-2492. PubMed ID: 32040728
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic value of metabolic tumour volume and total lesion glycolysis in
    Jiménez-Ballvé A; García García-Esquinas M; Salsidua-Arroyo O; Serrano-Palacio A; García-Sáenz JA; Ortega Candil A; Fuentes Ferrer ME; Rodríguez Rey C; Román-Santamaría JM; Moreno F; Carreras-Delgado JL
    Rev Esp Med Nucl Imagen Mol; 2016; 35(6):365-372. PubMed ID: 26948652
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The metabolic parameters based on volume in PET/CT are associated with clinicopathological N stage of colorectal cancer and can predict prognosis.
    Kido H; Kato S; Funahashi K; Shibuya K; Sasaki Y; Urita Y; Hori M; Mizumura S
    EJNMMI Res; 2021 Sep; 11(1):87. PubMed ID: 34487264
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metabolic activity via
    Song J; Li Z; Yang L; Wei M; Yang Z; Wang X
    BMC Cancer; 2022 Jul; 22(1):808. PubMed ID: 35869469
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.
    Hong JH; Min KJ; Lee JK; So KA; Jung US; Kim S; Eo JS
    Medicine (Baltimore); 2016 Mar; 95(9):e2992. PubMed ID: 26945420
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer.
    Ulaner GA; Eaton A; Morris PG; Lilienstein J; Jhaveri K; Patil S; Fazio M; Larson S; Hudis CA; Jochelson MS
    Cancer Med; 2013 Oct; 2(5):725-33. PubMed ID: 24403238
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of
    Wang X; Yang W; Zhou Q; Luo H; Chen W; Yeung SJ; Zhang S; Gan Y; Zeng B; Liu Z; Feng S; Zhang X; Cheng C
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4241-4251. PubMed ID: 35732974
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of [¹⁸F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer.
    Caicedo C; Garcia-Velloso MJ; Lozano MD; Labiano T; Vigil Diaz C; Lopez-Picazo JM; Gurpide A; Zulueta JJ; Richter Echevarria JA; Perez Gracia JL
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2058-65. PubMed ID: 24990403
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.
    Hofheinz F; Li Y; Steffen IG; Lin Q; Lili C; Hua W; van den Hoff J; Zschaeck S
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1485-1494. PubMed ID: 30949816
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Value of (18)F-FDG PET-CT imaging to predict epidermal growth factor receptor mutations in patients with lung squamous cell carcinoma].
    Zhao CY; Deng XY; Wang HS; Cao GP; Ding JN; Ding CY
    Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):795-800. PubMed ID: 34289575
    [No Abstract]   [Full Text] [Related]  

  • 73. Alternative volumetric PET pjmirometers for evaluation of breast cancer cases with 18F-FDG PET/CT imaging: Metabolic tumour volume and total lesion glycolysis.
    Arslan E; Can Trabulus D; Mermut Ö; Şavlı TC; Çermik TF
    J Med Imaging Radiat Oncol; 2021 Feb; 65(1):38-45. PubMed ID: 33084216
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Value of metabolic parameters in distinguishing primary mediastinal lymphomas from thymic epithelial tumors.
    Zhu L; Li X; Wang J; Fu Q; Liu J; Ma W; Xu W; Chen W
    Cancer Biol Med; 2020 May; 17(2):468-477. PubMed ID: 32587782
    [No Abstract]   [Full Text] [Related]  

  • 75. Clinical value of metabolic PET parameters of primary vulvar carcinoma.
    Yanarateş A; Budak E; Budak A; Inan AH; Kanmaz AG; Oral A; Yazici B
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(6):367-371. PubMed ID: 34752370
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
    Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH
    J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy.
    Sharma A; Mohan A; Bhalla AS; Sharma MC; Vishnubhatla S; Das CJ; Pandey AK; Sekhar Bal C; Patel CD; Sharma P; Agarwal KK; Kumar R
    Clin Nucl Med; 2018 Jan; 43(1):e8-e17. PubMed ID: 29112011
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic value of
    Kitajima K; Yamano T; Miyoshi Y; Katsuura T; Enoki T; Yamakado K
    Hell J Nucl Med; 2019; 22(1):25-35. PubMed ID: 30843007
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Role of the Metabolic Parameters of
    Wang D; Liu X; Wang W; Huo L; Pan Q; Ren X; Zhang F; Hu K
    Front Oncol; 2021; 11():698744. PubMed ID: 34490094
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.